UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

Neurology, 2008-07, Vol.71 (2), p.136-144

2008

Volltextzugriff (PDF)

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

Clinical and experimental immunology, 2014-03, Vol.175 (3), p.397-407

2014

Volltextzugriff (PDF)

Monoclonal antibodies in treatment of multiple sclerosis

Clinical and experimental immunology, 2014-03, Vol.175 (3), p.373-384

2014

Volltextzugriff (PDF)

Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1098-1106

2008

Volltextzugriff (PDF)

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study

Neurology, 2012-04, Vol.78 (15), p.1171-1178

2012

Volltextzugriff (PDF)

Neuroinflammation of the central and peripheral nervous system: an update

Clinical and experimental immunology, 2014-03, Vol.175 (3), p.333-335

2014

Volltextzugriff (PDF)

Prion proteins: a biological role beyond prion diseases

Acta neurologica Scandinavica, 2007-08, Vol.116 (2), p.75-82

2007

Volltextzugriff (PDF)

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

Neurology, 2009-02, Vol.72 (5), p.396-401

2009

Volltextzugriff (PDF)

Monoclonal antibodies in the therapy of multiple sclerosis: An overview

Journal of neurology, 2008-12, Vol.255 (Suppl 6), p.28-35

2008

Volltextzugriff (PDF)

Multiple sclerosis therapy : An update on recently finished trials

Journal of neurology, 2007-11, Vol.254 (11), p.1473-1490

2007

Volltextzugriff (PDF)

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab: Evidence for disease heterogeneity

Journal of neurology, 2008-09, Vol.255 (9), p.1436-1438

2008

Volltextzugriff (PDF)

The potential therapeutic role of statins in central nervous system autoimmune disorders

Cellular and molecular life sciences : CMLS, 2003-11, Vol.60 (11), p.2483-2491

2003

Volltextzugriff (PDF)

Musica e crisi sonora: atti dei Convegni internazionali di studi, Firenze, 4 dicembre 1999, 8-9 novembre 2001, 21 settembre 2002

Stüve, Michael

2004

Volltextzugriff (PDF)

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity

The Journal of clinical investigation, 2006-04, Vol.116 (4), p.1037-1044

2006

Volltextzugriff (PDF)

Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial

Multiple sclerosis, 2010-06, Vol.16 (6), p.715-723

2010

Volltextzugriff (PDF)

Teriflunomid zur Behandlung der Multiplen Sklerose

Nervenarzt, 2013-06, Vol.84 (6), p.724-731

2013

Volltextzugriff (PDF)

Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis

Neurotherapeutics, 2016-01, Vol.13 (1), p.58-69

2016

Volltextzugriff (PDF)

The Absence of Interictal Spikes with Documented Seizures Suggests Extratemporal Epilepsy

Epilepsia (Copenhagen), 2001-06, Vol.42 (6), p.778-781

2001

Volltextzugriff (PDF)

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9

Annals of neurology, 1996-12, Vol.40 (6), p.853-863

1996

Volltextzugriff (PDF)

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

Nature reviews. Neurology, 2013-05, Vol.9 (5), p.267-276

2013

Volltextzugriff (PDF)

Interferon β-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9

Annals of neurology, 1996-12, Vol.40 (6), p.853-863

1996

Volltextzugriff (PDF)

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

Neuropsychiatric disease and treatment, 2011-01, Vol.7 (1), p.519-527

2011

Volltextzugriff (PDF)

Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis

Current opinion in neurology, 1999-08, Vol.12 (4), p.395-401

1999

Volltextzugriff (PDF)

Tumefactive demyelination following herbal supplement use: Cause or coincidence?

Journal of postgraduate medicine, 2016-04, Vol.62 (2), p.136-137

2016

Volltextzugriff (PDF)

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

Nature (London), 2002-11, Vol.420 (6911), p.78-84

2002

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(70)
Humans
(62)
Neurosciences & Neurology
(55)
Clinical Neurology
(48)
Multiple Sclerosis
(33)
Neurology
(33)
Biological And Medical Sciences
(27)
Medical Sciences
(26)
Neurosciences
(26)
Female
(21)
Male
(21)
Multiple Sclerosis - Drug Therapy
(21)
Animals
(20)
Adult
(15)
Multiple Sclerosis - Immunology
(13)
Immunology
(12)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(11)
Middle Aged
(11)
Natalizumab
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

Monoclonal antibodies in treatment of multiple sclerosis

Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study

Neuroinflammation of the central and peripheral nervous system: an update

Prion proteins: a biological role beyond prion diseases

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

Monoclonal antibodies in the therapy of multiple sclerosis: An overview

Multiple sclerosis therapy : An update on recently finished trials

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab: Evidence for disease heterogeneity

The potential therapeutic role of statins in central nervous system autoimmune disorders

Musica e crisi sonora: atti dei Convegni internazionali di studi, Firenze, 4 dicembre 1999, 8-9 novembre 2001, 21 settembre 2002

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity

Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial

Teriflunomid zur Behandlung der Multiplen Sklerose

Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis

The Absence of Interictal Spikes with Documented Seizures Suggests Extratemporal Epilepsy

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

Interferon β-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis

Tumefactive demyelination following herbal supplement use: Cause or coincidence?

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

Suchergebnisse filtern